The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome.

@article{Nardo2009TheRB,
  title={The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome.},
  author={Luciano G. Nardo and Allen P. Yates and Stephen A. Roberts and Philip W. Pemberton and Ian Laing},
  journal={Human reproduction},
  year={2009},
  volume={24 11},
  pages={
          2917-23
        }
}
BACKGROUND Hyperandrogenaemia and insulin resistance are prominent features of polycystic ovary syndrome (PCOS) and influence the process of folliculogenesis in women with the endocrinopathy. Anti-Müllerian hormone (AMH) levels are elevated in women with PCOS and studies including IVF subjects have shown that this is a reliable marker of ovarian performance. The aims of this prospective study were to assess the relationship between insulin resistance, androgens and AMH, and whether AMH… 
Evaluation of relationship between serum levels of anti-müllerian hormone, androgen, and insulin resistant with retrieval oocytes in overweight patients with polycystic ovary syndrome
TLDR
The finding provides that increasing BMI with direct effect on AMH levels and IR can affect the number of follicles, which are retrieved in polycystic ovary syndrome patients.
INTERRELATIONSHIP OF AMH WITH CLINICAL, HORMONAL AND SONOGRAPHIC PARAMETERS IN PATIENTS WITH POLYCYSTIC OVARIAN DISEASE
TLDR
Increased AMH concentration in correlation with increased cycle length in cases of oligomenorrhea, clinical hyperandrogenism, increased LH, increased AFC and increased ovarian volume is found.
The Relation of Serum Anti-Mullerian Hormone with Polycystic Ovary Syndrome: Correlation with Clinical and Hormonal Parameters
TLDR
Increased AMH levels in PCOS possibly due to increased number of small antral follicles and there was no correlation between the AMH and other clinical or hormonal parameters, however, large scale studies are needed to define the metformin effect on hormonal outcome.
Increased androgen, anti-Müllerian hormone, and sporadic anovulation in healthy, eumenorrheic women: a mild PCOS-like phenotype?
TLDR
Mechanisms of androgen-related ovulatory dysfunction that characterize PCOS in women with menstrual disturbances may occur across a continuum of T concentrations, including in eumenorrheic women without clinical hyperandrogenism.
Anti-Müllerian hormone levels in women with polycystic ovarian syndrome compared with normal women of reproductive age in China
  • X. Tian, X. Ruan, +6 authors Ying Zhang
  • Medicine
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • 2014
TLDR
AMH may be a useful parameter to assess the severity and prognosis of PCOS since certain differences exist to normo-ovulatory women, and for the first time AMH levels across reproductive lifespan in Chinese women are assessed.
Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 47 REFERENCES
The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome.
TLDR
The results suggest that not only the AMH level, but also obesity, IR and elevated androgen levels may relate to the development of the large size of antral follicle pool and ovarian volume in women with PCOS.
Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
TLDR
Serum AMH levels decreased with age both in healthy women and in women with PCOS, although they were always 2- to 3-fold higher and remained elevated until 40 years of age in PCOS subjects, and the measurement of AMH could be used as a tool to assess ovarian ageing.
Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.
TLDR
The data suggest that the increase of AMH serum level in PCOS is the consequence of the androgen-induced excess in small antral FN and that each follicle produces a normal amount ofAMH.
Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome.
TLDR
High elevated AMH in follicular fluid from PCOS patients in contrast to age-matched normal controls suggests an intrinsic abnormality in the ovarian follicles themselves in PCOS, which could contribute to disordered folliculogenesis.
Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility.
TLDR
It is shown that serum AMH concentrations decrease over time both in women presenting with WHO 2 anovulatory infertility and in normo-ovulatory controls, and this observation may suggest retarded ovarian ageing and hence a sustained reproductive life span in these patients.
Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism.
TLDR
Serum AMH levels declined gradually throughout COH in the three groups, but remained higher in groups A and B compared with the controls, and multiple regression analysis revealed that both the number of small follicles and serum androgens were correlated to AMH.
Dynamics of FSH-induced follicular growth in subfertile women: relationship with age, insulin resistance, oocyte yield and anti-Mullerian hormone.
TLDR
Age showed little impact on the initial follicular cohort, but a significant impact upon the secondary cohort, while insulin resistance appeared to promote the former category alone, and Circulating AMH appears to represent all categories of antral follicles observed.
Anti-Mullerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome.
TLDR
Using quantitative RT-PCR, AMH,AMH receptor II, FSHR, and AR genes were shown to be overexpressed by GCs from stimulated follicles of women with PCOS undergoing controlled ovarian hyperstimulation, which could be the sign of a maturation defect or may reflect hyperandrogenism.
Anti-Müllerian hormone levels and antral follicle count in women enrolled in in vitro fertilization cycles: Relationship to lifestyle factors, chronological age and reproductive history
The aims of this prospective study were to investigate the relationship between anti-Müllerian hormone (AMH) and antral follicle count (AFC), and to determine whether these markers of ovarian reserve
Insulin-lowering medications in polycystic ovary syndrome.
  • A. Taylor
  • Medicine, Biology
    Obstetrics and gynecology clinics of North America
  • 2000
...
1
2
3
4
5
...